Vaccines

KHN’s ‘What the Health?’: As Cases Spike, White House Declares Pandemic Over

  • by

Can’t see the audio player? Click here to listen on SoundCloud. White House chief of staff Mark Meadows said this week that “we’re not going to control the pandemic,” effectively conceding that the administration has pivoted from prevention to treatment. But COVID-19 cases are rising rapidly… Read More »KHN’s ‘What the Health?’: As Cases Spike, White House Declares Pandemic Over

KHN on the Air This Week

  • by

KHN chief Washington correspondent Julie Rovner discussed the impact of the election and the upcoming Supreme Court challenge on the Affordable Care Act with New Hampshire Public Radio’s “The Exchange” and WNYC’s “The Brian Lehrer Show” on Wednesday. Rovner also spoke with Newsy’s “Morning Rush”… Read More »KHN on the Air This Week

GSK Presents Results of Maternal & Older Adults RSV Vaccines at IDWeek 2020

  • by

Shots: GSK reported that its RSV vaccines for maternal immunization (GSK3888550A) and older adults (GSK3844766A) were well-tolerated and highly immunogenic in P-I/II clinical studies. Both the candidate vaccines contain a recombinant RSVPreF3, that triggers the required immune response The GSK3844766A was first tested in 48… Read More »GSK Presents Results of Maternal & Older Adults RSV Vaccines at IDWeek 2020

Flu Season 2020: Why it’s time to talk to your doctor today about getting a flu shot

  • by

As America’s biopharmaceutical companies work around the clock to combat COVID-19, another virus with deadly consequences is right around the corner. The COVID-19 pandemic has led to more than 7.5 million infections and tragically more than 210,000 deaths. The influenza virus, more commonly known as… Read More »Flu Season 2020: Why it’s time to talk to your doctor today about getting a flu shot

In Debate, Pence and Harris Offer Conflicting Views of Nation’s Reality

  • by

The Trump administration’s pandemic response: decisive action that saved lives, or the greatest failure of any presidential administration? During Wednesday’s vice presidential debate, Vice President Mike Pence and the Democratic challenger, Sen. Kamala Harris of California, offered drastically different takes — from behind  plexiglass screens… Read More »In Debate, Pence and Harris Offer Conflicting Views of Nation’s Reality

Republican Convention, Day 4: Fireworks … and Shining a Light on Trump’s Claims

  • by

President Donald Trump accepted the Republican Party’s nomination for president in a 70-minute speech from the South Lawn of the White House on Thursday night. Speaking to a friendly crowd that didn’t appear to be observing social distancing conventions, and with few participants wearing masks,… Read More »Republican Convention, Day 4: Fireworks … and Shining a Light on Trump’s Claims

The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

  • by

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient access to breakthrough therapies. Innovators are also relying on these strong protections to discover new medical advances that will keep patients… Read More »The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

Pfizer, BioNTech start late-stage study of Covid-19 vaccine

  • by

The companies said they had started a Phase II/III trial BNT162b2. The news comes the day after Moderna announced the launch of its Phase III study and days after Pfizer and BioNTech signed a nearly $2 billion vaccine supply deal with the federal government.

New report shows more than 400 medicines and vaccines in development to tackle infectious diseases, including COVID-19

  • by

Throughout history, infectious diseases caused by pathogens such as bacteria or viruses have taken a devastating toll on the lives and security of people around the world. With the ongoing COVID-19 pandemic gripping the world, we are experiencing a challenging situation that we haven’t seen… Read More »New report shows more than 400 medicines and vaccines in development to tackle infectious diseases, including COVID-19

FDA guidance eases some Covid-19 vaccine concerns, but others remain

  • by

Amid fears of a premature emergency use authorization for a Covid-19 vaccine granted for political reasons, the guidance that the FDA released at the beginning of the month sets much tougher standards. But trial enrollment, anti-vaccine sentiment and other potential problems persist.

FDA Maps Expectations for COVID Vaccine Proposals

With more than 100 vaccine research programs looking to address the pandemic, FDA officials are moving to clarify standards and requirements for vetting and approving viable preventives. The agency recently issued a lengthy guidance outlining recommendations for documenting vaccine quality,

GSK, Medicago Collaborate on Covid-19 Vaccine Candidate

GlaxoSmithKline (GSK) and Medicago have announced a collaboration for the development and evaluation of a COVID-19 vaccine candidate. The collaboration was revealed in a July 7, 2020 press release. The candidate vaccine will combine Medicago s recombinant coronavirus virus-like particles (

How biopharmaceutical researchers are ensuring COVID-19 vaccines will be safe and effective­

  • by

As the world continues to feel the impact of COVID-19, the biopharmaceutical industry is working around the clock to identify and develop safe and effective vaccines to prevent infection, while also researching and developing new therapies to treat those infected with the virus. Given the… Read More »How biopharmaceutical researchers are ensuring COVID-19 vaccines will be safe and effective­